Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial (Q36251995)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial |
scientific article |
Statements
1 reference
Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial (English)
1 reference
Nancy Bartlett
1 reference
Anne H Blaes
1 reference
Bruce A Peterson
1 reference
David L Dunn
1 reference
Vicki A Morrison
1 reference
1 October 2005
1 reference
Identifiers
1 reference